Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon KohdenNHNKF 69 EV-to-EBIT is 10.05 as of Aug. 09, 2026, which is 20% below its 10-year median of 12.57. GuruFocus rates NHNKF with a GF Score™ of 69/100 and a GF Value™ of $22.94 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 472 Medical Devices & Instruments companies, Nihon Kohden ranks better than 76.91% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Nihon Kohden's Enterprise Value for the quarter that ended in Mar. 2026 was $2,276 Mil.
Nihon Kohden's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $131 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Kohden EV-to-EBIT Related Terms
Nihon Kohden EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Nihon Kohden's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nihon Kohden's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Kohden EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nihon Kohden's EV-to-EBIT falls into.
Nihon Kohden's current Enterprise Value is $1,320 Mil.
Nihon Kohden's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $131 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Kohden (NHNKF) has a EV-to-EBIT of 10.05 as of Aug. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nihon Kohden and its competitors. This is 20% below median its historical median of 12.57. Over the past decade, Nihon Kohden's EV-to-EBIT has ranged from 5.19 to 21.65. According to the industry distribution chart, Nihon Kohden ranks #109 out of 472 companies in the Medical Devices & Instruments industry, placing it in the top 23.1%.
Is Nihon Kohden's EV-to-EBIT too high?
Nihon Kohden's current EV-to-EBIT of 10.05 is 20% below median its 10-year median of 12.57. Over the past 10 years, this metric has ranged from a low of 5.19 to a high of 21.65. The Medical Devices & Instruments industry median EV-to-EBIT is 19.02. Nihon Kohden's value of 10.05 is 47.2% below this industry median. Based on the distribution chart, Nihon Kohden ranks #109 out of 472 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nihon Kohden has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nihon Kohden's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nihon Kohden ranks #109 out of 472 companies for EV-to-EBIT. This places Nihon Kohden in the top 23% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 19.02. Nihon Kohden's value of 10.05 is 47.2% below this benchmark. Historically, Nihon Kohden's own EV-to-EBIT has ranged from 5.19 to 21.65 over the past decade. While the company's 10-year median is 12.57 vs. the industry median of 19.02, Nihon Kohden has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.02, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Kohden's current EV-to-EBIT of 10.05 is 47.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nihon Kohden and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Kohden's current EV-to-EBIT is 10.05, which is 20% below median its own 10-year median of 12.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Kohden stock overvalued right now?
Based on GuruFocus' analysis, Nihon Kohden (NHNKF) is currently considered Significantly Undervalued. The stock's GF Value™ is $22.94, compared to a current price of $9.82 — trading 57.2% below its estimated fair value. The current EV-to-EBIT is 10.05, which is 20% below median its 10-year median of 12.57 and 47.2% below the Medical Devices & Instruments industry median of 19.02. Nihon Kohden's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Nihon Kohden (NHNKF), the current EV-to-EBIT is 10.05 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Kohden (NHNKF) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Kohden stock appears to be undervalued.
The current stock price of $9.82 is trading 57.2% below its estimated GF Value™ of $22.94.
GuruFocus considers Nihon Kohden to be Significantly Undervalued.
Key valuation signals for NHNKF:
EV-to-EBIT: 10.05 (20% below median its 10-year median of 12.57)
GF Value™: $22.94 vs. price of $9.82 (57.2% below fair value)
Industry Position: 47.2% below the Medical Devices & Instruments median (#109 of 472)
No single metric tells the full story. See the NHNKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
69GF Score
Get the complete analysis for NHNKF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHNKF has been successfully added to your 
